13D Filing: James E. Flynn and AveXis Inc (AVXS)
AveXis Inc (NASDAQ:AVXS): James E. Flynn's Deerfield Management filed an amended 13D.
You can check out Deerfield Management's latest holdings and filings here.
Avexis Inc. (AVXS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Eversept Partners Kamran Moghtaderi | 0 | $0 | 0% | |
| 2. | Paloma Partners Donald Sussman | 0 | $0 | 0% | |
| 3. | Element Capital Management Jeffrey Talpins | 0 | $0 | 0% | |
| 4. | Acuta Capital Partners Manfred Yu | 0 | $0 | 0% | |
| 5. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 5,000 | Officer | 5,000 | 2016-02-10 | Filing | |
| $20.00 | 100,000 | Director | 1,035,657 | 2016-02-17 | Filing | |
| $20.00 | 112,000 | Large Shareholder, Director, Other | 112,000 | 2016-02-17 | Filing | |
| $20.00 | 88,000 | Large Shareholder, Director, Other | 88,000 | 2016-02-17 | Filing | |
| $20.00 | 163,702 | Large Shareholder, Director, Other | 413,611 | 2016-02-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $123.16 | 846 | Officer, Director | 1,755,602 | 2018-04-02 | Filing | |
| $122.29 | 1,182 | Officer, Director | 1,756,558 | 2018-04-02 | Filing | |
| $121.64 | 929 | Officer, Director | 1,757,630 | 2018-04-02 | Filing | |
| $120.18 | 3,179 | Officer, Director | 1,758,559 | 2018-04-02 | Filing | |
| $119.29 | 4,021 | Officer, Director | 1,761,738 | 2018-04-02 | Filing |
Institutional Investors' Holdings
News See All
13D Filing: James E. Flynn and AveXis Inc (AVXS)
AveXis Inc (NASDAQ:AVXS): James E. Flynn's Deerfield Management filed an amended 13D.
You can check out Deerfield Management's latest holdings and filings here.
13D Filing: James E. Flynn and AveXis Inc (AVXS)
You can access the original SEC filing by clicking here.
13D Filing: James E. Flynn and AveXis Inc (AVXS)
You can access the original SEC filing by clicking here.
Avexis Inc. (AVXS): RA Capital Management Ups Its Stake
Peter Kolchinsky's RA Capital Management has slightly raised its stake in Avexis Inc. (NASDAQ:AVXS), as per a new Form 13G with the Securities and Exchange Commission.
Hedge Funds Are Betting On AveXis Inc (AVXS)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
AveXis Inc (AVXS): Of Course The FDA Didn't Ask For Placebo Data
AveXis Inc (NASDAQ:AVXS) just announced that it has secured a favorable trial design for its ongoing investigation of its lead asset, AVXS-101, in its investigation into spinal muscular atrophy (SMA) ...
RA Capital's Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks
RA Capital Management LLC is a crossover fund manager that invests in public and private healthcare and life science companies developing drugs, medical devices and diagnostics.
13D Filing: James Flynn's Deerfield Management Takes 9.99% Stake in Newly-Public AveXis, Inc. (AVXS)
AveXis Inc (NASDAQ:AVXS) is the subject of a new 13D filing issued by James Flynn's Deerfield Management, which reveals a 2.24 million-share position in the stock, which you can see in the table below...